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Julian Eaton4
Late diagnosis and interventions characterize childhood neurodevelopmental disorders in Sub-Saharan 
Africa. This has negatively impacted on the prognosis of the children with neurodevelopmental 
disorders. This study examined the prevalence and pattern of neurodevelopmental delays among 
children under the age of 3 years attending immunization clinics in Lagos State, Nigeria and also affords 
opportunity of early follow-up and interventions, which had been documented to improve prognosis. 
The study involved two stage assessments; which consisted of first phase screening of the children for 
neurodevelopmental delays in immunization clinics at primary healthcare centers Lagos State, Nigeria 
and second phase which consists of definitive clinical evaluation and follow-up interventions for children 
screened positive for neurodevelopmental delays. Twenty seven (0.9%) of a total of 3,011 children 
under the age of 3 years were screened positive for neurodevelopmental delays and subsequently 
undergoing clinical evaluation and follow-up interventions. Preliminary working diagnoses among 
these children include cerebral palsy, autism spectrum disorder trait, nutritional deficiency, Down 
syndrome and Non-specific neurodevelopmental delay with co-morbid seizure disorder accounting for 
33.3%, 14.8%, 18.5%, 7.4% and 25.9% respectively. This is a preliminary report that would be followed 
up with information on medium and long term intervention phase.
Neurodevelopmental disorders (NDD) are group of disorders arising from impairments in the developing brain 
and/or the central nervous system. They are considered neurodevelopmental in that by definition they originate 
during the developmental period, that is, during the prenatal, ante-natal, post-natal, infancy and early childhood 
periods1. The disorders have varying degrees of associated burden on children, their families and their communi-
ties and almost always require multi-faceted services to address special educational, health care, social inclusion 
and rehabilitation needs1.
The NDD include intellectual developmental disorders with known genetic or metabolic etiologies, traumatic 
or congenital brain injuries including conditions such as cerebral palsy, as well as prenatal exposures such as fetal 
alcohol syndrome, and disorders of social relatedness such as autism spectrum disorders1.
With the declining under-five mortality in recent years, report suggests a possible future high prevalence par-
adigm shift from communicable diseases to childhood neurodevelopmental disorders in Sub-Saharan Africa as 
more children survive beyond the age of five years1.
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The study is part of a project titled, “Early Identification and Intervention for Childhood Neurodevelopmental 
Disorders among Children under the age of 3 years in Lagos State, Nigeria”. This project incorporates screening 
and interventional follow-up for neurodevelopmental disorders among children under the age of three years.
Prior to now, data are not available regarding the prevalence and pattern of neurodevelopmental disorders 
among young children under the age of 3 years in Nigeria and other sub-Saharan African countries. This is often 
as a result of late diagnosis and interventions that characterized neurodevelopmental disorders in this region, 
with earliest diagnoses often made at school age between the ages of 6 and 8 years, leading to late interventions 
for these children2. Details about factors that may be responsible for the late diagnosis in sub-Saharan Africa are 
contained in a previous review2.
Having baseline data about prevalence and pattern of neurodevelopmental delay in this age group would help 
healthcare and educational services planning for such children, who may have special education needs.
The Federal Government of Nigeria in 1999 introduced the National Program on Immunization (NPI) to 
replace the existing Expanded Program on Immunization (EPI) that was initiated in 1979. The NPI was estab-
lished with a key focus to provide support to the implementation of the State and Local Government Area (LGA) 
immunization programs3.
Immunization clinics at the primary healthcare centers constitute major clinical source of convergence for 
children under the age of 3 years and their mothers. The immunization clinic environment also affords the oppor-
tunity for early screening for neurodevelopmental delay among these children in a less stigmatizing setting.
This study assessed the prevalence and pattern of neurodevelopmental delays among children under the 
age of 3 years attending immunization clinics in primary health care centers in two randomly selected Local 
Government Areas (LGAs) of the twenty LGAs in Lagos State, Nigeria.
This is aimed at providing preliminary baseline data on prevalence and pattern of neurodevelopmental delays 
among children under the age of three years in Nigeria and also to provide early interventional follow up for these 
children, which had been documented to improve prognosis1.
The study is a preliminary report of the project titled, “Early Diagnosis and Interventions for Childhood 
Neurodevelopmental Disorders (NDD) among Children under the Age of 3 Years in Lagos State, Nigeria” sup-
ported by Grand Challenges Canada (GCC).
Methods
Location. The locations of the study were immunization clinics of primary healthcare centers in two of twenty 
Local Government Areas (LGAs) in Lagos State, South West Nigeria. Lagos State is the second most populous 
State in Nigeria after Kano out the 36 States and Federal Capital Territory (FCT) in Nigeria. It is sub-divided into 
20 Local Government Areas (LGAs). Each of the LGA is involved in National Program on Immunization (NPI) 
at Primary Health Care (PHC) level1.
Materials
Sociodemographic Questionnaire. This was used to obtain basic demographic information of the moth-
ers and children attending the immunization clinics.
WHO Child Growth Standard Charts. Growth charts are visible displays of a child’s physical growth 
and development4. WHO standard growth charts have two reference curves for both sexes in relation to weight 
for age, length for age and head circumference for age. Normal variations are assumed to include two stand-
ard deviations above and below the mean, that is, 3rd and 97th percentile. Recordings below the 3rd percentile 
would be said to be an indication of delayed growth. For this study, the weight for age, length for age and Head 
Circumference for age charts for both sexes were used. WHO Child Growth Standard Chart was used in this 
study to assess length for age, weight for age, and head circumference for age for each child studied, with the aim 
of further assessment for problem of malnutrition in a child with recording below 3rd percentile in any of the 
measured parameters.
Infant Development Inventory (IDI). The IDI has introductory part that asked the parents to describe 
their child generally and a second part that assessed the child development specifically in the areas of; Social; 
Self-Help; Gross Motor; Fine Motor and Language, which help to estimate the mental age of the child5. Further 
details about this Instrument can be found in the url link in the reference. This was used to screen for parental 
developmental concern in children within the age range of 0 to 18 Months.
Child Development Review (CDR). The CDR has introductory part that asked the parents to describe 
their child generally and a second part that assessed the child development specifically in the areas of; Social; 
Self-Help; Gross Motor; Fine Motor and Language, which help to estimate the mental age of the child6. The CDR 
also contained additional information or checklist of additional problems that the child may be experiencing. 
Further details about this Instrument can be found in the url link in the reference. This was used to screen for 
parental developmental concern in children above 18 Months of age.
CDC Mile Stone Moments (CDCMM). CDC Mile Stone Moments assessed child development specifically 
in the areas of; Social/Emotional; Language/Communication; Cognitive; Movement/Physical Development7. Further 
details about this Instrument can be found in the url link in the reference. This was used to screen for parental 
developmental concern in children within the age range of 0 to 36 Months.
Ethical Consideration
The objective of the study was explained to the mothers bringing their children to the immunization clin-
ics and their inform consent obtained before the screening and anthropometric measurements for the 
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children. The ethical approval for this study was obtained from the Institutional Review Board (IRB) of Federal 
Neuropsychiatric Hospital, Yaba, Lagos, Lagos State Nigeria. The methods for this project were carried out in 
accordance with the approved guidelines.
Procedure
The diagnostic procedure was in two phases consisting of screening and clinical evaluation:
First Phase. The first phase consisted of screening of the children for neurodevelopmental delays with IDI, 
CDR and CDCMM through parental report regarding the achievement of different milestones by the individual 
child. During this phase, anthropometric measurements of weight, length and head circumference were also 
done for individual child seen at immunization clinics. A total of 3,011 mothers (98.2%) out of the 3,065 mothers 
approached over a two year period of the project consented to screening and anthropometric measurement for 
their children. The children were screened consecutively as they attended immunization clinics. The first 1,500 
children were screened with either IDI5 and CDCMM7 or CDR6 and CDCMM7, depending on the age of a par-
ticular child at the time of screening. Based on the first 1,500 children screened, it was observed that CDCMM 
showed 100% sensitivity against IDI and CDR in detecting children with neurodevelopmental delays based on the 
parents’ report. The rest of the children (1,511) were screened with only CDC Milestone Moments7, because of the 
commercial implication of the other two screening tools (IDI and CDR). Out of a total of 3,011 children screened 
for neurodevelopmental delay, 27 (0.9%) screened positive for neurodevelopmental delay and were qualified for 
second phase which was definitive clinical evaluation and follow-up.
Second Phase. The second phase of clinical evaluation and follow-up interventions, presently ongoing at 
the Child and Adolescent Center of Federal Neuropsychiatric Hospital, Yaba, Lagos is examining the following 
parameters for each individual child screened positive for neurodevelopmental delay: developmental trajectory/
developmental milestone; cognitive trajectory/education needs assessment; adaptive functioning; biomedical 
profile; co-morbid physical health problems; nutritional components and definitive diagnosis. As the present 
period represents preliminary follow-up period, detail information about many of these parameters are presently 
inconclusive. For example, information about cognitive trajectory and adaptive functioning is presently not avail-
able, as assessment of these parameters is deferred till school age, which is about six (6) years in this environment. 
Assessment of cognitive trajectory and adaptive functioning would follow the methods highlighted in a previous 
publication in this environment8, in view of lack of standardized culturally adaptive tools. However, we are able to 
report at this time pattern of preliminary diagnoses we are working with among the 27 children screened positive 
for neurodevelopmental delays. The preliminary diagnoses were made following diagnostic criteria specified in 
the International Classification of Diseases, tenth Edition (ICD-10). The average follow-up period till date for 
these children is about three (3) months.
Results
A total of 3,011 children were screened at the immunization clinics under the primary healthcare centers of two 
Local Government Areas of Mushin and Oshodi in Lagos State, South West Nigeria. This figure represents 98.2% 
of total numbers of children and mothers approached to be screened.
Out of the total of 3,011 children screened, there are 1,587 female children (52.7%) and 1,424 male children 
(47.3%). The age range of the children screened and followed up over the two year period of the project is 3 to 36 
months. Mean age was about 6.0 months at the point of first screening. Each child screened was followed up for 
at least 6 months following the first screening to rule out any fresh sign of neurodevelopmental delay after the 
first screening.
A total of 27 children (0.9%) were screened positive for neurodevelopmental delay. Out of this total, there are 
14 males (1.0%) and 13 females (0.8%), showing that male children are more likely to experience neurodevelop-
mental delay. However, this difference was not statistically significant (X2 = 0.23, df = 1, p = 0.634). The age range 
of children with neurodevelopmental delay is 3 to 31 months. Their mean age is 12.8 ± 8.9 months, with a median 
age of 9.0 months. Table 1 showed gender information of children screened positive for neurodevelopmental 
delay.
Preliminary working diagnoses pattern. Table 2 showed preliminary working diagnoses pattern of chil-
dren screened positive for neurodevelopmental delays and other follow up information till date. Cerebral palsy, 
Autism Spectrum Disorder trait, Nutritional deficiency, Down Syndrome and Non-Specific neurodevelopmental 
delay with co-morbid seizure disorder accounted for 33.3%, 14.8%, 18.5%, 7.4% and 25.9% of the neurodevelop-




Children with Developmental Delay 
N (%)
Male 1,424 (47.3) 14 (1.0)
Female 1,587 (52.7) 13 (0.8)
Total 3,011 (100) 27 (0.9)
Table 1.  Gender Distribution of children screened positive for developmental delay.
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Discussion
In the first phase of the screening at the immunization clinics, this study adopted the approach of using screen-
ing tools to elicit parental concerns about development of their children under the age of three (3) years. This 
approach combined the two methods of screening with tools and eliciting parental concerns, both of which had 
been identified as effective ways of early screening for neurodevelopmental and behavioral problems9. It has been 
documented that parental information and concerns are important in early detection of neurodevelopmental 
problems in affected children10–12.
Prevalence of neurodevelopmental delays among children under the age of three years in this study was 
found to be 0.9%. Cerebral palsy, Autism Spectrum Disorder trait, Nutritional deficiency, Down Syndrome and 
Non-Specific neurodevelopmental delay with co-morbid seizure disorder accounted for 33.3%, 14.8%, 18.5%, 
7.4% and 25.9% of this prevalence respectively.
Male children are more likely to experience neurodevelopmental delay compare to the female children. 
However, this difference is not statistically significant.
It is difficult to compare these findings with previous studies, because this is probably the first time that neu-
rodevelopmental delay screening would be focusing on young children under the age of three years at immuniza-
tion clinic setting in a Sub-Saharan African sub-region.
Late diagnosis and interventions have characterized neurodevelopmental disorders in Sub-Saharan African 
children population despite usual early parental concern about development2. As a result of late interventions for 
children with neurodevelopmental disorders in the region, their optimal functioning is not achieved as depicted 
by many of them not having access to any form of education and impairment in expressive language ability2.
The need to diagnose early neurodevelopmental disorder and thus provide early interventions and follow-up 
which had been documented to improve prognosis1,2 informs this study.
Follow-up for these children would continue through fortnight clinical appointments at the tertiary care 
center, Child and Adolescent Center of Federal Neuropsychiatric Hospital, Yaba, Lagos, Nigeria.
Limitation
The study provides preliminary data that cannot be generalized as at present. There is need for Government 
buy-in to produce a nationally representative data that would be useful for healthcare and educational services 
planning for children with neurodevelopmental disability in the country.
Conclusions
The findings of this study showed preliminary data about prevalence and pattern of neurodevelopmental delays in 
children under the age of three years in Nigeria. Expanding this process nationally in Nigeria would afford availa-
bility of baseline data that can help in healthcare and educational services planning for this group of children with 
neurodevelopmental disability. The process would also afford early follow-up and interventions for the children 
with the ultimate aim of improving their functioning and prognosis.
Future direction should focus on lobbying for and enacting legislations that would promote community inclu-
sion for children and adults with neurodevelopmental disability in Nigeria.
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